Leaky Gut Syndrome A 34-year-old female with IBS symptoms and post-antibiotic dysbiosis completed a 90-day low-dose protocol (0.3mg daily), with notable improvement in bloating, bowel regularity, and gut-related fatigue
In a large phase 3 obesity trial (ACHIEVE-1), orforglipron at daily doses of 3, 12 and 36 mg caused approximately: Diarrhoea: 1926% of participants (vs 9% on placebo) Nausea: 1318% (vs 2% on placebo) Constipation: 817% (vs 4% on placebo) Vomiting: 514% (vs 1% on placebo) Across multiple studies, 617% of people stopped treatment because of side effects, mostly gut-related symptoms
For lab follow-up, symptom review, or injection planning between visits, TeleHealth may help refine the next step in your B12 plan
Second, people compare it to older weight loss drugs like fen-phen, which caused valvular heart disease
Quick 15-minute emergency dinners Some nights, all you have is 15 minutes and zero motivation
Glucagon-like peptide-1 (GLP-1), an incretin secreted by L-cells lining the gastrointestinal epithelium, has important functions: promoting insulin secretion, insulin sensitivity, and -cell mass, while inhibiting gastric emptying and appetite